RxDoctor Payments Data

Courtney Hawkins, PA

Physician Assistant · State College, PANPI 1194038562

Payments from drug & device makers

$3,632in general payments, 2019–2025

Across 242 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$603
  • AbbVie$494
  • Alkermes, Inc.$391
  • Teva Pharmaceuticals USA, Inc.$326
  • Neurocrine Biosciences, Inc.$321
  • Axsome Therapeutics, Inc.$289
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,58599%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,632 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$2,782
Medicare patients
13
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole19$27,410
VraylarCariprazine Hcl13$17,535
Chlorpromazine Hcl11$5,140
Aripiprazole29$2,398
Buspirone Hcl69$1,417
Trazodone Hcl95$1,143
Duloxetine Hcl58$1,079
Prazosin Hcl41$1,067
Vilazodone Hcl12$1,049
Bupropion XlBupropion Hcl61$849
Gabapentin55$644
Lorazepam30$393
Lamotrigine47$289
Topiramate15$283
Venlafaxine Hcl ErVenlafaxine Hcl20$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$244$27,41019 claims
AbbVieVraylar$494$17,53513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →